25.05.2022 • News

Dr. Paul Lohmann partners with AloxX and the Otto von Guericke University Magdeburg

Dr. Paul Lohmann announces the cooperation with AloxX and the Otto von Guericke University Magdeburg (OVGU) in the field of innovative corrosion protection additives under the brand Lohtragon CP.

The three parties intend to sign an exclusive licensing agreement covering novel corrosion protection additives. Based on the invention of the Swiss company AloxX and the OVGU, Dr. Paul Lohmann will exclusively be in charge of production, product optimization as well as global sales and marketing of this additive range. The technology has the potential to replace most corrosion additive packages currently in use in aqueous systems. The industry is put under immense pressure towards the R&D of environmentally sustainable solutions. Lohtragon CP is categorized as a GRAS (generally recognized as safe) chemical and demonstrates an important step towards reinventing the corrosion industry.

A full range of Lohtragon CP products will be developed during an initial pilot phase to make sure to meet all the requirements of the customers.

© Dr. Paul Lohmann
© Dr. Paul Lohmann

Company

Logo:

Dr. Paul Lohmann GmbH & Co. KGaA

Hauptstr. 2
31860 Emmerthal
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read